Back to Search
Start Over
Programmed death-1 inhibitor for occupational intrahepatic cholangiocarcinoma caused by chlorinated organic solvents.
- Source :
-
Journal of hepato-biliary-pancreatic sciences [J Hepatobiliary Pancreat Sci] 2019 Jun; Vol. 26 (6), pp. 242-243. Date of Electronic Publication: 2019 May 13. - Publication Year :
- 2019
-
Abstract
- Highlight Tanaka and Kubo reported the first case of recurrent occupational cholangiocarcinoma treated with programmed death-1 inhibitor. A programmed death-1 inhibitor was administered every 2 weeks for para-aortic lymph node metastasis after curative hepatectomy. After seven cycles of administration, positron emission tomography demonstrated diminished lymph node size without <superscript>18</superscript> F-fluorodeoxy glucose uptake.<br /> (© 2019 Japanese Society of Hepato-Biliary-Pancreatic Surgery.)
- Subjects :
- Adult
Bile Duct Neoplasms diagnostic imaging
Bile Duct Neoplasms surgery
Biomarkers, Tumor blood
Cholangiocarcinoma diagnostic imaging
Cholangiocarcinoma surgery
Fluorodeoxyglucose F18
Hepatectomy
Humans
Male
Positron-Emission Tomography
Radiopharmaceuticals
Antineoplastic Agents, Immunological therapeutic use
Bile Duct Neoplasms chemically induced
Bile Duct Neoplasms drug therapy
Chlorine Compounds toxicity
Cholangiocarcinoma chemically induced
Cholangiocarcinoma drug therapy
Nivolumab therapeutic use
Occupational Exposure adverse effects
Solvents toxicity
Subjects
Details
- Language :
- English
- ISSN :
- 1868-6982
- Volume :
- 26
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Journal of hepato-biliary-pancreatic sciences
- Publication Type :
- Academic Journal
- Accession number :
- 30945442
- Full Text :
- https://doi.org/10.1002/jhbp.623